Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts.

Fibroblasts perform critical functions during the normal host response to tissue injury, but the inappropriate accumulation and persistent activation of these cells results in the development of tissue fibrosis. The mechanisms accounting for the aberrant accumulation of fibroblasts during fibrotic repair are poorly understood, although evidence supports a role for fibroblast resistance to apoptosis as a contributing factor. We have shown that TGF-β1 and endothelin-1 (ET-1), soluble mediators implicated in fibrogenesis, promote fibroblast resistance to apoptosis. Moreover, we recently found that ET-1 induced apoptosis resistance in normal lung fibroblasts through the upregulation of survivin, a member of the Inhibitor of Apoptosis (IAP) protein family. In the current study, we sought to determine the role of survivin in the apoptosis resistance of primary fibroblasts isolated from the lungs of patients with Idiopathic Pulmonary Fibrosis (IPF), a fibrotic lung disease of unclear etiology for which there is no definitive therapy. First, we examined survivin expression in lung tissue from patients with IPF and found that there is robust expression in the fibroblasts residing within fibroblastic foci (the "active" lesions in IPF which correlate with mortality). Next, we show that survivin expression is increased in fibroblasts isolated from IPF lung tissue compared to cells from normal lung tissue. Consistent with a role in fibrogenesis, we demonstrate that TGF-β1 increases survivin expression in normal lung fibroblasts. Finally, we show that inhibition of survivin enhances susceptibility of a subset of IPF fibroblasts to apoptosis. Collectively, these findings suggest that increased survivin expression represents one mechanism contributing an apoptosis-resistant phenotype in IPF fibroblasts.

[1]  B. Hinz,et al.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. , 2012, The American journal of pathology.

[2]  H. Collard,et al.  Burden of illness in idiopathic pulmonary fibrosis , 2012, Journal of medical economics.

[3]  T. Maher Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment. , 2012, Clinics in chest medicine.

[4]  S. Hatakeyama,et al.  YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model , 2011, Anti-cancer drugs.

[5]  Gang Liu,et al.  New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis , 2011, Drugs.

[6]  M. Pavlyukov,et al.  Survivin Monomer Plays an Essential Role in Apoptosis Regulation* , 2011, The Journal of Biological Chemistry.

[7]  R. Hubbard,et al.  The rising incidence of idiopathic pulmonary fibrosis in the UK , 2011, Thorax.

[8]  D. Citrin,et al.  Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin , 2011, Molecular Cancer.

[9]  S. Cinghu,et al.  Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy. , 2011, Acta biochimica et biophysica Sinica.

[10]  H. Collard,et al.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[11]  D. Altieri Survivin and IAP proteins in cell-death mechanisms. , 2010, The Biochemical journal.

[12]  A. Nicholson,et al.  Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[13]  V. Pulkkinen,et al.  Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis. , 2010, American journal of respiratory cell and molecular biology.

[14]  K. Matsuno,et al.  Identification of a small-molecule inhibitor of the interaction between Survivin and Smac/DIABLO. , 2010, Biochemical and biophysical research communications.

[15]  K. Brown,et al.  Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis. , 2010, American journal of respiratory cell and molecular biology.

[16]  J. Whitsett,et al.  Inhibition of PI3K by PX-866 prevents transforming growth factor-alpha-induced pulmonary fibrosis. , 2010, The American journal of pathology.

[17]  E. White,et al.  Prostaglandin E2 induces fibroblast apoptosis by modulating multiple survival pathways , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  M. Duffy,et al.  Survivin: a new target for anti-cancer therapy. , 2009, Cancer treatment reviews.

[19]  D. Altieri,et al.  Survivin as a global target of intrinsic tumor suppression networks , 2009, Cell cycle.

[20]  David S. Rogers,et al.  Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation. , 2009, American journal of respiratory cell and molecular biology.

[21]  C. Duckett,et al.  Diverse functions within the IAP family , 2008, Journal of Cell Science.

[22]  D. Altieri New wirings in the survivin networks , 2008, Oncogene.

[23]  C. Ruppert,et al.  Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.

[24]  R. Chambers,et al.  Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis. , 2008, Proceedings of the American Thoracic Society.

[25]  J. Becker,et al.  The Universal Character of the Tumor-Associated Antigen Survivin , 2007, Clinical Cancer Research.

[26]  K. Anderson,et al.  Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells , 2007, British journal of haematology.

[27]  R. Homer,et al.  Semaphorin 7A plays a critical role in TGF-β1–induced pulmonary fibrosis , 2007, The Journal of experimental medicine.

[28]  David S. Rogers,et al.  Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. , 2007, Cellular signalling.

[29]  N. K. Sah,et al.  Structural, functional and therapeutic biology of survivin. , 2006, Cancer letters.

[30]  J. Horowitz,et al.  Idiopathic Pulmonary Fibrosis , 2006, Treatments in respiratory medicine.

[31]  J. Horowitz,et al.  Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. , 2006, Proceedings of the American Thoracic Society.

[32]  T. Standiford,et al.  Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[33]  K. Brown,et al.  TNF-α Sensitizes Normal and Fibrotic Human Lung Fibroblasts to Fas-Induced Apoptosis , 2006 .

[34]  T. Welte,et al.  Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis , 2005, Respiratory research.

[35]  A. Desmoulière,et al.  Perspective Article: Tissue repair, contraction, and the myofibroblast , 2005, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[36]  R. Nho,et al.  Focal Adhesion Kinase Is Upstream of Phosphatidylinositol 3-Kinase/Akt in Regulating Fibroblast Survival in Response to Contraction of Type I Collagen Matrices via a β1 Integrin Viability Signaling Pathway* , 2004, Journal of Biological Chemistry.

[37]  V. Keshamouni,et al.  Activation of the Pro-survival Phosphatidylinositol 3-Kinase/AKT Pathway by Transforming Growth Factor-β1 in Mesenchymal Cells Is Mediated by p38 MAPK-dependent Induction of an Autocrine Growth Factor* , 2004, Journal of Biological Chemistry.

[38]  D. Livant,et al.  Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. , 2003, American journal of respiratory and critical care medicine.

[39]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[40]  S. Rosselot Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[41]  David S. Rogers,et al.  Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis. , 2012, The international journal of biochemistry & cell biology.

[42]  M. L. R. D. Christenson,et al.  An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management , 2012 .

[43]  F. Martinez,et al.  Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia. , 2008, American journal of respiratory and critical care medicine.

[44]  J. Joven,et al.  Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats , 2007, Molecular and Cellular Biochemistry.

[45]  K. Brown,et al.  TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis. , 2006, American journal of respiratory cell and molecular biology.

[46]  A. Desmoulière,et al.  Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. , 1995, The American journal of pathology.